By continuing to use this site you consent to the use of cookies on your device. Find out more about our cookie policy and the types of cookies we use by clicking here.

Franklin Biotechnology Discv A Acc $

Performance History31/01/2016
Growth of 1,000 (EUR)
Franklin Biotechnology Discv A Acc $
Fund24.957.253.416.9-22.4
+/-Cat0.26.04.9-2.5-1.2
+/-Idx-16.9-3.34.5-3.0-7.7
 
Key Stats
NAV
05/02/2016
 USD 24.21
Day Change -3.51%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
31/12/2015
 USD 2744.68
Share Class Size (Mil)
31/12/2015
 USD 2240.50
Max Initial Charge 5.75%
Ongoing Charge
20/01/2016
  1.81%
Investment Objective: Franklin Biotechnology Discv A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns05/02/2016
YTD-28.38
3 Years Annualised23.67
5 Years Annualised23.55
10 Years Annualised11.43
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Steven Kornfeld
15/09/2015
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A Acc $31/10/2015
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks92.310.0092.31
Bonds0.000.000.00
Cash5.290.005.29
Other2.390.002.39
Top 5 Regions%
United States95.20
United Kingdom2.51
Canada1.23
Middle East0.57
Eurozone0.31
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Gilead Sciences IncHealthcareHealthcare9.50
Celgene CorpHealthcareHealthcare8.66
Biogen IncHealthcareHealthcare6.19
Amgen IncHealthcareHealthcare5.11
Incyte CorpHealthcareHealthcare4.13
Franklin Biotechnology Discv A Acc $